Lara McGrath

Company: AstraZeneca

Job title: Director - Translational Medicine

Seminars:

Advancing AstraZeneca’s Clinically Active EGFR/MET Bispecific ADC in Phase I of Development 3:45 pm

Sharing data on the development of a bispecific ADC targeting EGGFR & MET Leveraging a Topoisomerase I inhibitor and two ligand recruitment mechanism of action for improved efficacy Exploring how AstraZeneca’s bispecific ADC is progressing through clinical developmentRead more

day: Conference Day One PM